Symptomatic and quality of life response to tolterodine in subgroups of men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia

[1] Milsom I(2001)How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study BJU Int 87 760-766

[2] Abrams P(2004)Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder BJU Int 94 817-820

[3] Cardozo L(2003)Combination treatment with an alpha-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study J Urol 169 2253-2256

[4] Roberts RG(2004)Use of muscarinic receptor antagonists as monotherapy in men with lower urinary tract symptoms who failed previous therapy with alpha blockers J Urol 171 917-590

[5] Thuroff J(2005)Combination therapy using alpha-blocker and antimuscarinic drugs in men with lower urinary tract symptoms suggestive of bladder outlet obstruction and an overactive bladder: is it safe and efficacious? Neurourol Urodyn 24 205-7

[6] Wein AJ(2003)Leitlinien der Deutschen Urologen zur Diagnostik des benignen Prostatasyndroms (BPS) Urologe A 42 584-2275

[7] Lee JY(2006)Drug treatment for LUTS and BPH: new is not always better Eur Urol 49 5-536

[8] Kim HW(2005)Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia J Urol 174 2273-1004

[9] Lee SJ(1999)A comparative study of the efficacy and safety of tamsulosin hydrochloride alone and combination of propiverine hydrochloride and tamsulosin in the benign prostatic hypertrophy with pollakiuria and/or urinary incontinence Jpn J Urol Surg 12 525-855

[10] Koh JS(2006)Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction J Urol 175 999-554

[1] Milsom I(2001)How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study BJU Int 87 760-766

[2] Abrams P(2004)Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder BJU Int 94 817-820

[3] Cardozo L(2003)Combination treatment with an alpha-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study J Urol 169 2253-2256

[4] Roberts RG(2004)Use of muscarinic receptor antagonists as monotherapy in men with lower urinary tract symptoms who failed previous therapy with alpha blockers J Urol 171 917-590

[5] Thuroff J(2005)Combination therapy using alpha-blocker and antimuscarinic drugs in men with lower urinary tract symptoms suggestive of bladder outlet obstruction and an overactive bladder: is it safe and efficacious? Neurourol Urodyn 24 205-7

[6] Wein AJ(2003)Leitlinien der Deutschen Urologen zur Diagnostik des benignen Prostatasyndroms (BPS) Urologe A 42 584-2275

[7] Lee JY(2006)Drug treatment for LUTS and BPH: new is not always better Eur Urol 49 5-536

[8] Kim HW(2005)Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia J Urol 174 2273-1004

[9] Lee SJ(1999)A comparative study of the efficacy and safety of tamsulosin hydrochloride alone and combination of propiverine hydrochloride and tamsulosin in the benign prostatic hypertrophy with pollakiuria and/or urinary incontinence Jpn J Urol Surg 12 525-855

[10] Koh JS(2006)Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction J Urol 175 999-554